相关产品推荐更多 >

EZElisa™人脱磷酸辅酶A激酶结构域蛋白(DCAKD)ELISA试剂盒-EZElisa™ Human Dephospho-CoA Kinase domain-containing Protein (DCAKD) ELISA Kit
询价
EZElisa™人甲基乙二醛(MGO)ELISA试剂盒-EZElisa™ Human Methylglyoxal (MGO) ELISA Kit
询价
EZElisa™肌球蛋白轻链2(MYL2)ELISA试剂盒-EZElisa™ Myosin Light Chain 2 (MYL2) ELISA Kit
询价
Necitumumab ELISA试剂盒-Necitumumab ELISA Kit
询价
EZElisa™人Prominin 1(PROM1)ELISA试剂盒-EZElisa™ Human Prominin 1 (PROM1) ELISA Kit
询价
万千商家帮你免费找货
0 人在求购买到急需产品
- 详细信息
- 文献和实验
- 技术资料
- 保存条件:
运输过程中保存:2-8℃
- 保质期:
1年
- 英文名:
EZElisa™ Human Lymphocyte Antigen 86 (LY86) ELISA Kit
- 库存:
100
- 供应商:
艾美捷科技
EZElisa™人淋巴细胞抗原86(LY86)ELISA试剂盒,EZElisa™ Human Lymphocyte Antigen 86 (LY86) ELISA Kit,淋巴细胞抗原86(LY86)ELISA试剂盒, Lymphocyte Antigen 86 (LY86) ELISA Kit
产品名称:EZElisa™人淋巴细胞抗原6复合位点蛋白G6d(LY6G6D)ELISA试剂盒-EZElisa™ Human Lymphocyte Antigen 86 (LY86) ELISA Kit
产品货号:A-QEK05148-96wells
产品规格:96wells

Enzyme Immunoassay for the estimation of Lymphocyte Antigen 86 (LY86) in serum and plasma, tissue homogenates and other biological fluids.
种属:Human
检测方法:比色法
检测范围:

该EZElisa™人淋巴细胞抗原86(LY86)ELISA试剂盒ELISA的特点包括:即用即用的操作步骤标准化和高重复性批次之间的一致性准确性和精确性经过七个点的验证,符合金环标准质量ELISA的要求,这是Biogradetech质量的基准标志。EZElisa™ ELISA试剂盒用于评估样品中的特定生物标志物,样品可以是血清

运输过程中保存:2-8℃
点击:EZElisa™人淋巴细胞抗原6复合位点蛋白G6d(LY6G6D)ELISA试剂盒-EZElisa™ Human Lymphocyte Antigen 86 (LY86) ELISA Kit更多Biogradetech产品信息价格,货期,产品说明,百度搜“艾美捷科技”进入官网网站,查看具体产品且快速下单。

风险提示:丁香通仅作为第三方平台,为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全,合理判断,谨慎选购商品,商家和用户对交易行为负责。对于医疗器械类产品,请先查证核实企业经营资质和医疗器械产品注册证情况。
文献和实验kinase (p56 lck ) that phosphorylates the CD3 complex.Proc Natl Acad. Sci USA,1989;86:3277. 5.Baixeras E, et al. Signal transduction pathways involved in B cell induction. Immunological Reviews,1993;132:5. 6.Blumberg RS, et al
kinase (p56 lck ) that phosphorylates the CD3 complex.Proc Natl Acad. Sci USA,1989;86:3277. 5.Baixeras E, et al. Signal transduction pathways involved in B cell induction. Immunological Reviews,1993;132:5. 6.Blumberg RS, et al
【翻译】Development trends for monoclonal antibody cancer therapeutics
receptor TRAILR1 (HGS-ETR1; Human Genome Sciences) directly trigger apoptosis of tumour cells38. In addition, two human mAbs (CP-675,206; Pfizer, and ipilimumab; Medarex) that target cytotoxic T lymphocyte-associated antigen 4 (CTLA4) are undergoing Phase
技术资料暂无技术资料 索取技术资料




